Encode Ideas publishes both sponsored and unsponsored research. Some companies in our coverage retain us for awareness and distribution; others we cover on our own initiative. The Current and Past Engagements below identify every company that compensates us now or has in the past, so you can see which coverage carries a paid relationship. Assume our coverage may be influenced by our positions and any sponsor relationship. We disclose every relationship, we make our calls publicly, and we own them — the wins and the losses.
Not investment advice
This content is for informational purposes only and is not, and should not be construed as, financial, investment, legal, or tax advice, nor a recommendation or solicitation to buy, sell, or hold any security. Neither Encode Ideas, LP, [Encode Ideas, LLC, and Encode, LLC — confirm full entity list], nor their operators, owners, employees, and affiliates (collectively, “Encode”) are registered investment advisers or broker-dealers in any jurisdiction, and no advisory or client relationship is created by your use of this site or email list. Never invest in any security featured here unless you can afford to lose your entire investment. Consult your own qualified financial, legal, and tax advisors before making any investment decision, and conduct thorough, independent research from multiple sources rather than relying solely on this content.
Positions and conflicts of interest
Encode and its principals, employees, and affiliates may hold long, short, or neutral positions in the securities of any company covered, some or all of which may have been acquired before this content was distributed, and may increase, decrease, or close those positions at any time without notice and regardless of any view expressed here. Because Encode is compensated by certain companies for awareness and research, always assume that compensation is a conflict of interest that may affect Encode’s objectivity regarding the companies it covers.
No warranty; accuracy
This content is provided “as is,” without warranty of any kind, express or implied. Information is drawn from the profiled companies or public sources believed to be reliable, but Encode makes no representations, warranties, or guarantees as to its accuracy, completeness, reliability, or timeliness, and there is a high possibility of inaccuracies. Any opinions are statements of judgment as of the publication date and are subject to change without notice.
Investment risk
Investing in micro-cap and small-cap securities is highly speculative and carries an extremely high degree of risk, including the potential loss of your entire investment. The securities discussed may not be suitable for all investors. None of this content constitutes an offer or solicitation to buy or sell any security, and no investment decision should be based on it.
Compensation Disclosure — Current Engagements
Encode Ideas, LP currently has compensated relationships with Satellos Biosciences (three hundred thousand options and twenty thousand dollars quarterly), Eupraxia Pharmaceuticals (seven thousand dollars monthly), and Ovid Therapeutics (eight thousand five hundred dollars monthly).
Past Engagements
Encode Ideas, LP has previously been retained for sponsored work and research by Delcath Systems, Ocuphire Pharma, Fennec Pharma, TLC, Processa Pharmaceuticals, Modular Medical, NervGen Pharma, Gain Therapeutics, Entera Bio, Protara Therapeutics, RenovoRx, and Cybin.
Forward-looking statements
This content may contain forward-looking statements involving risks and uncertainties. No assurance can be given that actual events or results will not differ materially from those anticipated. Factors that could cause material differences include, among others, clinical and preclinical trial results and timing; regulatory decisions by the FDA and other authorities; the need for and terms of additional financing and resulting dilution; competition; intellectual-property developments; and the other risks disclosed in the profiled companies’ filings with the Securities and Exchange Commission. Encode undertakes no obligation to update or revise any forward-looking statement.
Third-party links
Encode does not represent or warrant that any third-party website accessible through this one is accurate, complete, or current, and disclaims any liability for its content or omissions. Any linked site is independent of Encode, which has no control over and is not responsible for its content; a link is not an endorsement.
Limitation of liability
By using this website or email list, you agree to hold harmless, release, and indemnify Encode and its operators, owners, employees, and affiliates from any loss, damage, claim, or liability arising from your use of this content. In no event shall Encode be liable for any special, incidental, indirect, consequential, or other damages whatsoever — including loss of use, data, or profits — arising out of or in connection with your use of this website, its content, or its services, on any theory of liability, even if advised of the possibility of such damages. If any portion of this section is held unenforceable, liability will be limited to the fullest extent permitted by applicable law. Encode reserves the right to add, modify, or delete information at any time. This site has been compiled in good faith by Encode Ideas, LP.